Researcher Vivian Lipari, affiliated with the academic network of the Ibero-American University Foundation (FUNIBER), is participating in an international scientific study that analyzes the role of natural compounds in the prevention and treatment of Alzheimer’s disease. The research, published in the *International Journal of Molecular Sciences*, reviews clinical evidence and molecular mechanisms that explain how certain naturally occurring bioactive compounds could help address this neurodegenerative disease.
The study, titled Natural Products in Alzheimer’s Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms, brings together an international team of researchers that also includes Maurizio Battino, Francesca Giampieri, José L. Quiles, and Tamara Y. Forbes-Hernández. The research offers a systematic review of clinical trials and experimental studies exploring how different natural compounds may influence the biological processes related to the development of Alzheimer’s disease.
Alzheimer’s disease is currently one of the leading causes of dementia worldwide and represents one of the greatest challenges for healthcare systems due to the progressive aging of the population. This condition is characterized by a gradual deterioration of cognitive functions, particularly memory, language, and reasoning ability. Although pharmacological treatments exist to help alleviate some symptoms, therapies capable of halting or completely reversing the progression of the disease are not yet available.
In recent years, the scientific community has focused particularly on the potential of bioactive compounds found in foods and plants as allies in the prevention of neurodegenerative diseases. Many of these substances possess antioxidant and anti-inflammatory properties that could play an important role in protecting nerve cells from cellular damage.
The research in which Vivian Lipari is participating analyzes various natural products and nutraceuticals studied in clinical trials, including compounds found in plant-based foods, botanical extracts, and bioactive molecules with potential neuroprotective effects. The researchers reviewed the scientific literature to identify which compounds have shown promising results and what molecular mechanisms are involved in their effects.
The results compiled in the review reveal multiple potential mechanisms of action. Various natural compounds analyzed in clinical studies demonstrate the ability to reduce oxidative stress, one of the cellular processes associated with brain aging and the development of Alzheimer’s disease. This antioxidant effect helps protect neurons from damage caused by free radicals and other oxidizing agents.
Likewise, several of the compounds studied demonstrated anti-inflammatory properties, capable of modulating the inflammatory response in the nervous system. Chronic inflammation of brain tissue is considered one of the key factors in the progression of neurodegenerative diseases, so controlling it could have a significant impact on the course of the disease.
Another relevant aspect identified in the analysis is the possible influence of certain natural compounds on the accumulation of beta-amyloid proteins, one of the most well-known pathological hallmarks of Alzheimer’s disease. Some studies suggest that certain bioactive molecules could help reduce the formation or accumulation of these proteins in the brain.
The researchers highlight that certain natural compounds could promote communication between neurons and protect nerve cells, potentially helping to maintain cognitive functions for longer. Although the results are promising, the study emphasizes that further large-scale clinical research is still needed to fully confirm these effects and establish specific therapeutic recommendations.
If you want to learn more about this study, click here.
To read more research, check out the UNEATLANTICO repository.